Download PDF
VitaCyte uses Qualio to manufacture highly purified cell recovery reagents
Technology Category
- Application Infrastructure & Middleware - Data Exchange & Integration
- Cybersecurity & Privacy - Security Compliance
- Functional Applications - Enterprise Resource Planning Systems (ERP)
Applicable Functions
- Business Operation
- Quality Assurance
Use Cases
- Regulatory Compliance Monitoring
Services
- System Integration
- Training
The Challenge
VitaCyte began as an early-stage startup funded by an NIH grant as it pursued a commercialization path for reagents used for the recovery of cells used in human transplant therapies. From the outset, the VitaCyte team knew they would need a robust quality management system to achieve their goals. But with limited resources, that wasn’t really practical. So they built a paper-based system from the ground up knowing that they’d have to eventually migrate to something more sophisticated. VitaCyte manufactures ancillary reagents that are used in the preparation of cells, operating in an evolving, yet-to-be-fully defined regulatory space. Recently, the company was audited by a customer’s quality team, and the experience led VitaCyte to begin the process of searching for a new quality management system.
About The Customer
VitaCyte is a biotechnology company that manufactures high-purity tissue dissociation enzymes and cell recovery reagents, including collagenase. The company’s product portfolio is designed to correlate optimal enzyme activity with specific cell and tissue types to maximize viable cell yields. VitaCyte, which was founded in 2004 and is headquartered in Indianapolis, has 11 employees. The company operates in the niche regenerative medicine and cell therapy space, focusing on the preparation of cells for human transplant therapies. VitaCyte's products are used in an evolving regulatory environment, necessitating a robust quality management system to ensure compliance and operational efficiency.
The Solution
As VitaCyte began looking for a new solution, they examined a few eDoc platforms and found that most of them were feature-heavy and rigid, catering to established pharmaceutical businesses and manufacturers of already-certified materials. After exploring their options, VitaCyte ultimately decided that Qualio, the electronic quality management system (eQMS) built for medical device, biotech, and pharma companies, was best-suited for their needs. Qualio provided a powerful and adaptable quality management system that met VitaCyte's specific requirements. The platform offered seamless onboarding, with high-touch support from the Qualio team, enabling VitaCyte to migrate all their existing documents quickly. Qualio's system adopted VitaCyte's existing numbering and organization conventions, ensuring a smooth transition. Additionally, Qualio's secure and reliable architecture, with data encryption in transit and at rest, provided VitaCyte with the necessary security for their trade secrets.
Operational Impact
Quantitative Benefit
Related Case Studies.
Case Study
Remote Monitoring for Environmental Compliance
Emerson wanted to provide a connected environmental analyzer to their customers. They wanted to leverage IoT technologies to provide a software solution that was easy to use, real-time and centralized. Compliance with pollution control board guidelines and the ability to remotely calibrate and troubleshoot these devices was the primary objective. Requirements - Centralized Remote Monitoring. - IoT Based Smart Environmental Analyzers. - Remote Calibration and Troubleshooting. - User Friendly Application. - Reporting & Dashboards. - Compliance with pollution control board guidelines.
Case Study
ELI LILLY ADOPTS MICROMEDIA’S ALERT NOTIFICATION SYSTEM
Pharmaceutical production is subject to a strict set of enforced rules that must be adhered to and compliance to these standards is critically necessary. Due to the efforts of WIN 911’s strategic partner Micromedia, Lilly was able to adopt an alarm notification infrastructure that integrated smoothly with their existing workflows and emergency hardware and protocols. These raw energy sources enable the industrial process to function: electricity, WIN-911 Software | 4020 South Industrial Drive, Suite 120 | Austin, TX 78744 USA industrial steam, iced water, air mixtures of varying quality. Refrigeration towers, boilers and wastewater are monitored by ALERT. Eli Lilly identified 15000 potential variables, but limitations compelled them to chisel the variable list down to 300. This allowed all major alarms to be covered including pressure, discharge, quantity of waste water discharged,temperature, carbon dioxide content, oxygen & sulphur content, and the water’s pH.
Case Study
IoT Solutions Give Commercial Fishing Real-time insights
Technology to support vessels in the commercial fishing industry had not changed significantly since the advent of radar. Over the past 40 years commercial fishing in the United States has continued to be one of the most active, yet regulated industries. The combination of federal regulations and lack of technology created an opportunity for Faria Watchdog to go-to-market with a solution.
Case Study
Digital Transformation of FOSIS through AuraQuantic Platform
The Solidarity and Social Investment Fund (FOSIS), a service of the Chilean Government, was faced with the challenge of standardizing its administrative processes to comply with the new regulatory framework established by the Law of Digital Transformation of the State (LTDE). The LTDE focuses on updating administrative procedures and document management in public administration through digital transformation. It also mandates that all communication related to administrative procedures between different public bodies must be carried out electronically. FOSIS had been using the AuraQuantic platform for over 14 years to automate different internal processes. However, with the introduction of the new LTDE framework, the institution needed to launch an ambitious project to align with the new regulations.
Case Study
Big risks requires big data thinking: helping clients target and prevent fraud
EY's clients are increasingly seeking growth in markets with higher perceived levels of fraud, bribery, and corruption risk. Regulators and law enforcement bodies are intensifying their activities, leading to significant corporate investment in employee training, policy development, and internal audit procedures designed to raise awareness of anti-fraud or anti-corruption policies. Many companies have also increased the use of more sophisticated, proactive uses of forensic data analytics (FDA) capabilities designed to prevent and detect areas of fraud, waste, and abuse. However, traditional rules-based tests and spreadsheet tools are not effective in managing these risks. EY needed a solution that could help them get ahead of the curve and squash potential threats before they escalate.
Case Study
Fresenius Medical Care AG & Co. KGaA optimizes external financial reporting
Fresenius Medical Care wanted to optimize its reporting process, particularly in light of the increased demands made by regulatory authorities on external financial reporting. The preparation of financial reports in accordance with international accounting standards (IFRS and US-GAAP [Generally Accepted Account Principles]) as well as in different currencies (Euro and US dollars) is a very complex and expensive process. The legal importance and reputational value of these standardized quarterly and annual reports for listed companies require the financial reports to be of a consistently high quality. However, the requirements for the structure and content of these reports are constantly increasing, while the submission deadlines get tighter.